Molsidomine
| Status | Commercial |
| Development phase | |
| Therapeutic cat. | Cardiology |
| Polymorphic form | Substance does not show polymorphism |
| CAS No. | 25717-80-0 |
| Reference Product | |
| Injectable Form | |
| EU DMF readiness |  |
| CEP | |
| CHINESE DMF | |
| JAPANESE DMF | |
| KOREAN DMF | |
| CANADIAN DMF | |
| CADIFA | |
| US DMF readiness | |
| OEB No. | |
| Samples |
Drug description
Molsidomine is a long-acting vasodilator utilized for treating angina pectoris, and it is also effective in cases of left heart failure and acute myocardial infarction.
Polpharma API
- Extensive production experience
- Global market leader
- All intermediates produced in-house
Disclaimer
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
